Table 1. Demographic and clinical characteristics of the SIT Trial and CSSCD cohorts.
Variables | SIT Trial | CSSCD | P-value* |
---|---|---|---|
Sex, n (%) | |||
Men | 483 (52.2%) | 360 (52%) | 0.89 |
Age (in years), mean ± SD | 8.96 ± 2.44 | 9.57 ± 2.91 | 0.002 |
Baseline SBP† (mm Hg), mean ± SD | 108.2 ± 11.51 | 100.8 ± 10.99 | <0.001 |
Baseline DBP‡ (mm Hg), mean ± SD | 60.58 ± 8.06 | 59.21 ± 10.27 | 0.04 |
Height (cm), mean ± SD | 128.70 ± 14.37 | 131.5 ± 16.08 | 0.008 |
Hemoglobin (g/dl), mean ± SD | 8.11 ± 1.08 | 8.13 ± 0.96 | 0.41 |
Hematocrit (%), mean ± SD | 23.34 ± 3.42 | 23.57 ± 3.10 | 0.12 |
White blood counts (Cu), mean ± SD | 12.58 ± 5.25 | 12.01 ± 2.56 | 0.13 |
Fetal hemoglobin (%), mean ± SD | 8.93 ± 5.75 | 8.00 ± 7.45 | 0.014 |
The shown laboratory assessments for both the cohorts are at baseline
P-values for continuous and categorical variable comparisons were generated using wilcoxon rank sum and Kruskal-Wallis test, respectively
SBP indicates systolic blood pressure
DBP indicates diastolic blood pressure